chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around the same time as the vaccine I noticed that my heart rate would be very fast after only climbing a flight of stairs.  By September, 2021 my heart was skipping beats.  I visited my PCP and after testing it was determined that I have superventricular tachycardia.  Many causes for the SVT's:  thyroid, caffeine, smoking, drugs and alcohol were ruled out.  (I don't drink caffeinated beverages, my thyroid was ruled out by blood work, I don't smoke, take illegal drugs and minimal consumption of alcohol (less than two drinks a month.)    I might not have connected any dots to Covid or the vaccines until I heard that my vaccinnated brother, sister and two sisters in law also started having heart beat/palpatation problems in 2021 within months after vaccination.
I have had diaherria, vomiting, nausea for four days. when will it stop?
Pain and swelling at injection site, joint aches, chills, fatigue and slight nausea.
About a week and half after shot I noticed a large red spot on my arm where I received shot and it was swollen almost like a fluid sack underneath
Within two hours of the second dose,  I experienced a severe headache.  It has been two weeks since the injection and I still have a severe headache.  Blood pressure has also been elevated resulting in physician prescribing blood pressure medication.
Dizziness; Nausea; This case was reported by a pharmacist via call center representative and described the occurrence of dizziness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced dizziness and nausea. On an unknown date, the outcome of the dizziness and nausea were unknown.   It was unknown if the reporter considered the dizziness and nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced dizziness and nausea after receiving Shingrix. The reporter permitted for follow up.
contracted COVID-19 and tested positive with severe symptoms; contracted COVID-19 and tested positive with severe symptoms; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 36 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccinations within 4 weeks prior to the first administration date of the Pfizer vaccine. Vaccination history included: Bnt162b2, for COVID-19 immunisation, reactions: "burning eyes", "headache/severe headache", "minor muscle pain/severe muscle pain", "severe runny nose"; "chills", "migraine", "internal burning sensation", "insomnia", "sore throat", "coughing", "fatigue". On Oct2021, the patient contracted COVID-19 and tested positive with severe symptoms. The patient has not sought medical treatment due to the doctor saying there was not treatment unless the patient required hospitalization. The outcome of the events was unknown. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101675599 same patient and reporter, different dose and event
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Facility consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the DPHE on a compliance improvement plan and has been reinstated vaccination privileges.
This was the worsening of a chronic condition - my amount of Carbamazepine I was taking was increased. That failed to resolve the issue so another medication of Baclofen was added.  It has helped with my symptoms. I have surgery planned now for this. May 28th will be the date for that.
nausea; a little achiness; fatigue; stomach upset; "hot circle" at the injection site; sore left arm; headache; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach upset), VACCINATION SITE WARMTH ("hot circle" at the injection site), PAIN IN EXTREMITY (sore left arm), NAUSEA (nausea) and MYALGIA (a little achiness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020, Pharyngitis streptococcal, Ear infection, Bladder infection and Abdominal operation NOS. Concurrent medical conditions included Hypertension, IgG subclass deficiency, IgG subclass deficiency, Hypothyroidism, Allergic asthma, Occupational asthma, Fibromyalgia, Celiac disease, Interstitial lung disease (scar tissue narrowed airways), Egg allergy and Drug allergy (Allergic to Ceclor, cephalosporins, tetracycline, Demerol, ciprofloxacin, codeine, red dye #4, and macrodantin.). Concomitant products included QUINAPRIL, THYROID (ARMOUR THYROID), PROGESTERONE, IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE SOLUTION), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), GUAIFENESIN and ALBUTEROL SULFATE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 26-Feb-2021, the patient experienced VACCINATION SITE WARMTH ("hot circle" at the injection site), PAIN IN EXTREMITY (sore left arm), HEADACHE (headache) and VACCINATION SITE PAIN (pain at the injection site). On 27-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach upset), NAUSEA (nausea), MYALGIA (a little achiness) and FATIGUE (fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 26-Feb-2021 at an unspecified dose and frequency and IBUPROFEN on 26-Feb-2021 at an unspecified dose and frequency. On 01-Mar-2021, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (stomach upset), NAUSEA (nausea), MYALGIA (a little achiness), FATIGUE (fatigue), HEADACHE (headache) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown and VACCINATION SITE WARMTH ("hot circle" at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
sore arm; did not sleep well that night after receiving dose #2; chills; "slight fever"; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), INSOMNIA (did not sleep well that night after receiving dose #2), CHILLS (chills) and PYREXIA ("slight fever") in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 019B21A) for an unknown indication.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), INSOMNIA (did not sleep well that night after receiving dose #2), CHILLS (chills) and PYREXIA ("slight fever"). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Apr-2021, INSOMNIA (did not sleep well that night after receiving dose #2) outcome was unknown. On 03-Apr-2021, PAIN IN EXTREMITY (sore arm), CHILLS (chills) and PYREXIA ("slight fever") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Since 8/5/08, 2 wks after her 2nd GARDASIL shot, this girl has had severe back pain with diagnosis of Sacroileitis, pain Amplification syndrome.  Pain 7/10, fatigued.  Her best friend developed severity arthritis too after vaccine recently has missed 35 d of school 2008-9 5/19/09-records received-Office note 7/22/08 SI joint inflammed, positive for strep antibody.  Right complex adnexal cyst. 9/25/08-bulging L4/5, C/O pain when walking. 4/2/09-back pain no relief. Orthopaedic evaluation 8/29/08-orthopaedic evaluation. C/O bilateral should pain began 1 week prior now low back pain and upper back pain. Migraine headaches in past. Impression: acute back pain of unlear etiology. Impression: thoracic back pain of unclear etiology. 9/5/08-worsening back pain, impression:thoracic pain with component of cervical pain. Rheumatology consult 10/2/08-impression:pain amplification.
Client received the 1st COVIC vaccine of Moderna (Lot# 024C21A expiration 06/23/21). Client has completed 15 minutes in the observation area before feeling nauseated and a "slight headache". At 1803, EMT and Student Worker responded. At 1803, vital signs are blood pressure 146/100, heart rate 84, oxygen saturation 97%. At 1805, RN responds to this event. Client reports no known allergies, no medication, no past medical history. Client is offered supplemental nutrition and fluids. Client states "I was anxious coming here". RN addressed her concerns related to vaccines. Client denies nutrition, but accepts fluids. At 1812, vital signs are blood pressure 134/94, heart rate 74, oxygen saturation 97%. Client reports that nausea has resolved, no shortness of breath, no chest pain, but still has a "slight headache". RN educated Client about ED precautions and common adverse effects of the COVID vaccine. At 1819, vital signs are blood pressure 147/99, heart rate 79, oxygen saturation 98%. Client reports no changes and no new symptoms. Client reports her headache is the same and "manageable", and continues to drink water. At 1824, vital signs are blood pressure 129/93, heart rate 83, oxygen saturation 97%. Client reports no new symptoms and no changes. Client reports the present of the "slight headache" and continues to drink water. At 1834, Client stood up with no complaints and a steady gait. At 1835, Client left the facility with a steady gait.
Caller reports an adverse event happening. She experienced a rash, itching & pain. Patient uses a caption phone.
pt recv vax 15AUG95 & 6AUG96 pt devel a fever & chickenpox w/lesions covering all of body;pt exp required visit to MD;
MMR-V given 3/9/07. On 3/29/07, patient developed bruising/petechiae. Her platelet count was 6,000. She was admitted with diagnosis of ITP.
On 4/27/2022, patient, received a 0.2mL injection, which is the correct injection amount; however it was undiluted Pfizer Covid-19 vaccine formulated for ages 5-11by LVN.   When I spoke to LVN and her account was she felt overwhelmed and was moving quickly; she took the vial of the peds vaccine, which had been left to thaw, and drew up immediately instead of diluting it first with 1.3 mL of Sodium Chloride. When another nurse went to get a peds vaccine, they noticed that the vial looked empty and asked if it had been diluted and she realized her mistake. I walked in shortly after this had been realized; the patient and parents waited in observation, and I went to speak to Dr. She calculated that the patient received 28 micrograms of the vaccine, instead of the correct 10 micrograms. Per CDC and confirming with her, the patient could experience some exaggerated symptoms, including fever, chills, aches, and fatigue, and the best course of action is to have the parents monitor the patient. I spoke to the parents, informed them of what I discussed with Dr, and provided them with instructions to monitor the youngster.
pain & soreness in joints, neck, spine flu like sx; didn't receive any treatment, but took Advil; felt affects less than 1 wk;
Pt received the vaccine here on 04/26/2018. She stopped by the pharmacy May 9 and told us that her left arm was red, itchy and swollen all the way down to her wrist. She went to her primary doctor the day following the vaccine and he told her not to get the 2nd vaccine shot in the series for fear of an allergy.
Numbness in right foot and right leg, then spread to right hand.  Began in April and still ongoing.
Chills, nausea, body aches, joint pain, muscle aches, headache, swollen lymph nodes in neck
dizzy; throat started to close; the site of injection is itchy; The way that headaches goes, I never had something like that. I had to put myself in the dark, no noise, no nothing; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), THROAT TIGHTNESS (throat started to close), INJECTION SITE PRURITUS (the site of injection is itchy) and HEADACHE (The way that headaches goes, I never had something like that. I had to put myself in the dark, no noise, no nothing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Brain tumor and Seizures.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced DIZZINESS (dizzy), THROAT TIGHTNESS (throat started to close), INJECTION SITE PRURITUS (the site of injection is itchy) and HEADACHE (The way that headaches goes, I never had something like that. I had to put myself in the dark, no noise, no nothing). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy), THROAT TIGHTNESS (throat started to close), INJECTION SITE PRURITUS (the site of injection is itchy) and HEADACHE (The way that headaches goes, I never had something like that. I had to put myself in the dark, no noise, no nothing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient states that she was Allergic patient. The Concomitant medication included medication for seizures    Reporter did not allow further contact
She slept for 30 hours and was not answering her phone. She was  completely incoherent when my Husband went to check on her. An ambulance was called and she was in hospital for two nights.
neck and back pain; neck and back pain; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 09:15 (Lot number: EN6200) at the age of 61 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "covid positive", start date: Jan2021 (unspecified if ongoing), notes: covid positive; "Hypertensive" (unspecified if ongoing); "flat feet" (unspecified if ongoing); "obese" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number-1), for Covid-19 immunization. The following information was reported: NECK PAIN (non-serious), BACK PAIN (non-serious) all with onset 25Mar2021 15:00, outcome "not recovered" and all described as "neck and back pain". Therapeutic measures were taken as a result of neck pain, back pain.  Additional information: Patient did not receive any other vaccines within 4weeks prior to the COVID vaccine. No other medication in two weeks. Patient received shot and a couple hours later patient went back to work and worked the next few hours. Later that day and until now patient have had neck and back pain since receiving the second shot. Occasionally in the past patient Gert pain in neck or shoulder blade areas but it goes away in a few days. This pain has stayed with patient since got the injection. Sometimes the pain is somewhat sharp. It is not unbearable, but it is always there. Treatment included applied heat, massages. Prior to vaccination, patient not diagnosed with covid 19. Since the vaccination patient not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Information was received on 14-JUN-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. It was reported that the patient was inoculated with a dose of ZOSTAVAX (lot, expiration not reported) vaccine on or about 19-SEP-2014 at  a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster or shingles. On or about 08-SEP-2016, the patient broke out with a blistering vesicular rash accompanied by weakened immune symptoms and was treated by a physician's assistant at which time the patient's condition was diagnosed as severe herpes zoster shingles. The patient has been prescribed valacyclovir (VALTREX) for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain and suffering and other damages. Additional information has been requested.
Post vax, redness that night. Wed. 17:30 pm light rash all over in spots, 10:00 pm after shower, itching and bright red rash all over body with some swelling.Taken to hospital by mom. Given Benadryl, no difficulty breathing.
LETHARGY; FATIGUE; FEELING OUT OF ELEMENT; DRY MOUTH; LIGHT-HEADED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included many co-morbidities. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: 09-JUN-2021) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 19-MAR-2021 20:00, the subject experienced lethargy. On 19-MAR-2021 20:00, the subject experienced fatigue. On 19-MAR-2021 20:00, the subject experienced feeling out of element. On 19-MAR-2021 20:00, the subject experienced dry mouth. On 19-MAR-2021 20:00, the subject experienced light-headed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from lethargy, fatigue, feeling out of element, dry mouth, and light-headed. This report was non-serious.
N/A: reporting vaccine error. 1st dose Moderna was given in mistake, 1st dose 12+Pfizer should have been given due to patient age.
DTPa injection with rash in right thigh at injection site 1x2 cm. and IPV injection in with rash 5.5x3.5cm at injection site. Hib/Hep B injection in left thigh with 1.75cm reaction site. Tx recommended was Benedryl.
Nausea, cramps, diarrhea, aching, dizziness, headache
Pentacel combination immunization was ordered which included the DTaP,IPV and Haemophilus b Conjugate, This involves mixing the DTaP and IPV with the Haemophilus b Conjugate. I only gave the Hib component. This was noticed immediately and mother was notified, she was still in the office with the child. NP was notified and vaccine was re administered correctly as per protocol. Mother was informed of any potiential risk or harm and the mother and child left the office without any signs of distress or harm.
One week after having flu shot I started having a rash on lower right part of face (kind of like hives) also tingling and numbness of lips and cheek and a little bit of tickling/ tingling down into the right side of my throat. The tingling/numbness on my face started just below my lower lip on my chin on the right side yesterday (9/28/17) and has slowly spread out to my right cheek. There seems to be still a small rashy area on my chin just below my lower lip and some very slight swelling. I tried taking two generic Benadryl last night and also two this morning and it didn't seem to really help either time I took it.
Information has been received from a physician concerning a female patient who was vaccinated IM with a first dose of Gardasil (yeast). Subsequently the patient developed a shooting pain down her arm where she received the injection. Reportedly the physician does not think this is an adverse experience. Subsequently, the patient recovered from shooting pain down her arm in less than a minute. The patient does not want to come back for a second injection. Additional information has been requested.
Went shopping after I received the shot. Broke out in full body hives within an hour and a half after taking my first covid shot. Started on the lower back and spread to tummy area, arms.  Drank approx. 1/4 of children's liquid Benadryl to help with the hives. Headed home after drinking (& paying) for the Liquid Benadryl.
Ever since about 2-3 hours following my vaccination shot, I felt soreness in the left arm where I received the shot. It felt as if somebody punched me in the arm fairly hard and 2 days later I am still unable to move my left arm around too much. It is imperative that I can access my car whenever I need to so this is a major inconvenience for me and if this can be avoided or if all patients can know beforehand about this effect I would feel better about this entire thing. I did not know my arm would be sore for this long.
This spontaneous report as received from a nurse refers to roughly 20 unspecified patients of unknown age. On an unknown date, roughly 20 unspecified were vaccinated with VARIVAX (strength, dose, frequency, route of administration and indication were not provided) that reached 18.5 F for 10 hours and 44 minutes. This range was outside of storage conditions in product insert; however, in house stability data can support those conditions mentioned above that the VARIVAX was exposed to. No concomitant medication was reported. No adverse effects reported. No product quality complaint (PQC) was reported. The outcome of events was unknown. No further adverse event information was available. Follow up information (after previous telephone attempt to obtain follow up information which has been unsuccessful) has been received from a nurse concerning VARIVAX temperature excursion and one patient of unspecified age and gender who was vaccinated with VARIVAX (injection, strength, dose, frequency, route of administration and indication were not provided) (lot # J012384, exp date: 31-OCT-2015 also reported as 03-OCT-2015) that reached 18.5 F for 10 hours and 44 minutes. This is one of several reports received from the same source. Additional information has been requested.
onset of early menses (growth of public hair); This spontaneous report was received from a consumer via a company representative referring to a 9 year old female patient.  No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.    On an unspecified date in 2020, the patient was vaccinated with her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported).          On an unknown date, the patient experienced growth of pubic hair and onset of early menses (precocious puberty).  The patient sought unspecified medical attention.  No treatment was given for the event.  The outcome of the event and the causal relationship between the event and therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) were not provided.